⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNAC News
Cartesian Therapeutics, Inc. Common Stock
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027
globenewswire.com
RNAC
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
globenewswire.com
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grants
globenewswire.com
RNAC
Form 8-K
sec.gov
RNAC
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
RNAC
Cartesian Therapeutics Announces New Employment Inducement Grants
globenewswire.com
RNAC
Form 8-K
sec.gov
RNAC
Form 8-K
sec.gov
RNAC
Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
RNAC
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
RNAC